Resistance and conduit arteries following converting enzyme inhibition in hypertension

Journal of Vascular Research

Volumn 34, Issue 2, 1997, Pages 67-81

  Safar, Michel E ^a   Van Bortel, Luc M A B ^b   Struijker Boudier, Harry A J ^b  

^a HÔPITAL BROUSSAIS   (France)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Angiotensin converting enzyme; Hypertension; Vascular structure

Indexed keywords

AMILORIDE; ANTIHYPERTENSIVE AGENT; ATENOLOL; CAPTOPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; HYDROCHLOROTHIAZIDE; ISRADIPINE; LISINOPRIL; METOPROLOL; PERINDOPRIL; QUINAPRIL;

ARTERIOLE; ARTERY COMPLIANCE; ENZYME INHIBITION; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; REVIEW; VASCULAR RESISTANCE;

EID: 0031000563     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000159204     Document Type: Article

References (115)

1. Folkow B, Grirnby G, Thulesius O: Adaptive structural changes of the vascular wall in hypertension and their relation to the control of the peripheral resistance, Acta Physiol Scand 1958; 44:255-272.
2. Nichols WW, O'Rourke MF: McDonald's Blood Flow in Arteries; Theoretical, Experimental and Clinical Principles, ed 3. London, Arnold, 1990. pp 77-142. 216-269. 283-359. 398-437.
3. Safar ME: Pulse pressure in essential hypertension: Clinical and therapeutical implications, J Hypertens 1989;7:769-776.
4. O'Rourke M: Arterial stiffness, systolic pressure, and logical treatment of arterial hypertension, Hypertension 1990:15:339-347.
5. Van Bortel LM, Hoeks APG, Kool MJF, Struijkcr Boudier HAJ: Introduction to large artery properties as a target for risk reduction by antihypertensive therapy, J Hypertens 1992: 10(suppl 6): 123-126.
6. Guyton AC, Hall JE: Textbook of Medical Physiology, ed 9. Philadelphia, Saunders, 1994. chap 15. pp 171-176.
7. Kanncl WB, Gordon T, Schwartz MJ: Systolic versus diastolic blood pressure and risk of coronary heart disease: The Framingham Study, Am J Cardiol 1971;27:335-346.
8. Dame B, Girerd X, Safar M, Cambicn F, Guise L: Pulsatile versus diastolic blood pressure and risk of coronary heart disease: A cross-sectional analysis and a prospective analysis in cardiovascular mortalitv, Hypertension 1989:13: 392-400.
9. Scuteri A, Cacciafesta M, Di Bernardo MG, De Propris AM, Recchi D, Celli V, Cicconetli P, Marigliano V: Pulsatile versus steady-state component of blood pressure in elderly females: An independent risk factor for cardiovascular disease? J Hypertens 1995:13:185-191.
10. Fang J, Madhavan SH, Cohen H, Alderman MH: Measures of blood pressure and myocardial infarction in treated hypertensive patients, J Hypertens 1995;13:413-419.
11. Collins R, Peto R, MacMahon S, Hebert P, Fic-bach NH, Evcrlcy KA, Godwin J, Quizilbash N, Otaylor JCH: Blood pressure, stroke and coronary heart disease, Pt 2. Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context, Lancet 1990;335:827-838.
12. Safar ME: Therapeutics trials and large arteries in hypertension, Am Heart J 1988; 115:702-710.
13. Lin SY, Goodfricnd TL: Angiotensin receptors, Am J Physiol 1970;218:1319-1328.
14. Penit J, Faure M, Jard S: Vasopressin and angiotensin 11 receptors in rat aortic smooth muscle cells in culture, AmJ Physiol 1983.244: E72-E82.
15. Dzaa VJ, Safar ME: Large conduit arteries in hypertension: Role of the renin-angiotensin system, Circulation 1977;77:947-953.
16. Lever AF: Slow pressor mechanisms in hypertension: A role for hypertrophy of resistance vessels? J Hypertens 1986;4:515-524.
17. Bunkenburg B, van Amelsvoort T, Rogg H, Wood JM: Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats, Hypertension 1992;20:746-754.
18. Amal JF, Battle T, Rasctti C, Challah M, Cos-tcroussc O, Vicaut E, Michel JG, Alhenc-Gclas F: ACE in three lunicaeofrat aorta: Expression in smooth muscle and effect of renovascular hypertension, Am J Physiol 1994:36:111777-111784.
19. Gohlke P, Bunning P, Unger T: Distribution and metabolism of angiotensin I and II in the blood vessel wall, Hypertension 1992:20:151-157.
20. Gcisterfer AAT, Peach MJ, Owens GK: Angiotensin II induces hypertrophy, not hyperplasia of cultured rat aortic smooth muscle cells, Circ Res 1988:62:749-756.
21. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kancda Y, Ogihara T, Dzau VJ: Evidence for direct local effect of angiotensin in vascular hypertrophy, In vivo gene transfer of angiotensin converting enzyme, J Clin Invest 1994;94:978-984.
22. Kalo H, Suzuki H, Tajima S, Ogata Y, Tomi-naga T, Sato A, Saruta T: Angiotensin 11 stimulates collagen synthesis in cultured vascular smooth muscle cells, J Hyperlens 1991:9:17-22.
23. Griffin SA, Brwon WCB, MacPhcrson F, Mac-Grath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF: Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism, Hypertension 1991:17:626-635.
24. Simon G, Altman S: Suppressor angiotensin II is a bifunctional growth factor of vascular muscle in rats, J Hypertens 1992:10:1165-1171.
25. Richer C, Mulder P, Fomcs P, Richard V, Camilleri JP, Giudicelli JF: Hemodynamic and morphological effects of quinapril during genetic hypertension development, J C'ardiovasc Pharmacol 1991:18:621-642.
26. Christensen KL, Jcspcrsen LT, Mulvany MJ: Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure, J Hypertens 1989;7:83-90.
27. Linz W, Scholkens BA: A specific B2-bradyki-nin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril, Br J Pharmacol 1992;105:771-772.
28. Linz W, Scholkens BA, Ganter D: Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats, Clin Exp Hypertens 1989: 11:1325-1350.
29. Powell JS, Clozel JP, Muller RKM, Kuhn H, Hcfti F, Hosang M, Baumgartner HR: Inhibitors of angiotensin converting enzyme prevent mvointimal proliferation after vascular injury, Science 1989;245:186-188.
30. Mulvany MJ, Aalkjaer C: Structure and function of small arteries, Physiol Rev 1990:70:21 - 61.
31. Strauer BE: The coronary circulation in hypertensive heart disease, Hypertension 1984: 6(suppl III):74-80.
32. Schwartzkop IT B, Motz W, Frenzel II, Vogt M, Knaucr S, Eckchard Strauer B: Structural and functional alterations of the inlramyocardial coronary arterioles in patients with arterial hypertension, Circulation 1993:88:993-1003.
33. Freslon JL, Giudicelli JG: Compared myocardial and vascular effects of captopril and dihv-dralazinc during hypertension development in spontaneously hypertensive rats, Br J Pharmacol 1983;80:533-543.
34. Giudicelli JF, Freslon JL, Glasson S, Richer C: Captopril and hypertension development in the SHR, Clin Exp Hypertens 1980-, A2:183-196.
35. Harrap SB, Nicollacci JA, Dovlc AE: Persistent effects on blood pressure and renal hemodynamics following chronic angiotensin converting enzyme inhibition with pcrindopril, Clin Exp Pharmacol Physiol 1986;13:753-765.
36. Cadilhac M, Giudicelli JM: Myocardial and vascular effects of pcrindopril, a new converting enzyme inhibitor, during hypertension development in spontaneously hypertensive rats, Arch Int Pharmacodyn Ther 1986:284:114-126.
37. Christensen KL, Jespcrsen LT, Mulvany MJ: Development of blood pressure in spontaneously hypertensive rats after withdrawal of loiig-tcriu treatment related to vascular structure, J Hypertens 1989:7:83-90.
38. Mulvany MJ: Changes to the vascular system resulting from hypertension and their effects on response to therapy, Drugs 1990:39:9-20.
39. Christensen HRL, Nielsen H, Christensen KL, Baandrup U, Jcspcrsen LT, Mulvany MJ: Long-term hypotensive effects of an angiotensin converting enzyme inhibitor in spontaneously hypertensive rats: Is there a role for vascular structure? J Hvpertens 1988;6(suppl 3):27-31
40. Thybo NK, Korsgaard N, Erikscn S, Christensen KL, Mulvany MJ: Dose-dependent effects of pcrindopril on blood pressure and small-artcry structure, Hypertension 1994:23:659- 666.
41. Hajdu MA, Hcistad DD, Baumbach GL: Effects of antihypertensive therapy on mechanics of cerebral arterioles in rats, Hypertension 1991;17:308-316.
42. Hajdu MA, Heistad DD, Ghoneim S, Baumbach GL: Effects of antihypcrtensivc treatment on composition of cerebral arterioles, Hypertension 1991:18(suppl 2): 1115-1121.
43. Lee RMKW, Berecek KH, Tsoporis J, Mac-Kenzic R, Triggle CR: Prevention of hypertension and vascular changes by captopril treatment, Hypertension 1991.17:141-150.
44. Shaw LM, George PR, Oldham AA, Heagerty AM: A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries, J Hypertens 1995:13:1135-1143.
45. Rizzoni D, Castellano M, Portcri E, Bcttoni G, Muiesan ML, Cinelli A, Agabati-Rosei E: Effects of low and high doses of fosinopril on the structure and function of resistance arteries, Hypertension 1995:26:118-123.
46. Schiffrin EL, Deng LY, Larochelle P: Effects of a beta-blockcr or a converting cnzvmc inhibitor on resistance arteries in essential hypertension, Hypertension 1994:23:83-91.
47. Schiffrin EL, Deng LY, Larochelle P: Progressive improvement in the structure of resistance arteries of hypertensive pat ients after 2 years of treatment with an angiotensin l-converting enzyme inhibitor, Comparison with effects of a beta-blockcr, Am J Hvpertens 1995:8:229- 236.
48. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ: Effects of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension, Hypertension 1995:25:474-481.
49. Kool MJ, Lustermans FA, Breed JG, Struijkcr Boudier HA, Hocks AP, Rcncman RS, Van Bortel LM: The influence of pcrindopril and the diuretic comination amiloride + hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients, J Hypertens 1995; 13:839-848.
50. Halpcm W, Osol G, Coy GS: Mechanical behavior of pressurized in vitro pre-artcriolar vessels determined with a video system, Ann Biomed Eng 1984;12:463-479.
51. Fallon BJ, Bund SJ, Tulip JR, Heagerty AM: In vitro perfusion studies of resistance artery' function in genetic hypertension, Hypertension 1993:22:486-495.
52. Agalrti-Rosei E, Rizzoni D, Castellano M, Por-teri E, Zulli R, Muiesan ML, Bettoni G, Salvct-ti M, Muiesan P, Giulini SM: Mediadumen ratio in human small resistance arteries is related to forearm minimal vascular resistance, J Hypertens 1995;13:341-347.
53. Safar ME, London GM: The arterial system in human hypertension; in Swales KJ (ed): Textbook of Hypertension, London, Blackwell Scientific, 1994. chap 6. pp 85-102.
54. Cox RH: Basis for the altered arterial wall mechanics in the spontaneously hypertensive rat, Hypertension 1981:3:485-495.
55. Hayoz D, Rutschmann B, Perret F, Niedelbcr-ger M, Tardy Y, Mooser V, Nussberger J, Wac-ber B, Brunner HR: Conduit artery compliance and distensibility are not necessarily reduced in hypertension, Hypertension 1992;10:1-6.
56. Roman MJ, Saba PS, Pini R, Spitzer M, Pickering TG, Rosen S, Alderman MH, Devereux RB: Parallel cardiac and vascular adaptation in hypertension, Circulation 1992:86:1909-1918.
57. Gircrd X, Mourad JJ, Copie X, Moulin C, Acar C, Safar M, Laurent S: Non-invasive detection of an increased vascular mass in untreated hypertensive patients, Am J Hypertens 1994:7: 1076-1084.
58. Levy BI, Michel JL, Salzmann JL, Azizi M, Poitevin F, Safar ME, Camilleri JP: Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension, Circ Res 1988:63:227-229.
59. Armentano R, Mcgnien JL, Simon A, Bcllen-fant F, Barra J, Lcvcnson J: Effects of hypertension on visco-elasticity of carotid and femoral arteries in humans, Hypertension 1995:26:48-54.
60. Van Gorp AW, Van Ingen Schenau DS, Hoeks APG, Struijkcr Boudicr HAJ, Rcneman RS, Dc Mey JGR: Aortic wall properties in normo-tensive and hypertensive rats of various ages in vivo, Hypertension 1995:26:363-368.
61. Liu Z, Ting C-T, Zhu S, Yin FCP: Aortic compliance in human hypertension, Hypertension 1989;140:129-136.
62. Levy BI, Michel JL, Salzmann JL, Poitevin F, Devissaguct M, Scalbcrt E, Safar ME: Longterm effects of angiotensin-converting enzyme inhibition on the arterial wall of adult spontaneously hypertensive rats, Am J Cardiol 1993; 7L8E-16E
63. Levy BI, Bcncssiano J, Poitevin P, Safar ME: Endothelium-dependent mechanical properties of the carotid artery in WKY and SHR, Role of angiotensin converting enzyme inhibition, Circ Res 1990:66:321-328.
64. Bcnctos A, Pannier B, Brahimi M, Safar ME, Levy BI: Dose-related changes in the mechanical properties of the carotid artery in WKY rats and SHR following relaxation of arterial smooth muscle, J Vase Res 1993:30:23-29.
65. Capulo L, Tcdgui A, Levy BI: Control of carotid vasomotor tone by local renin-angiotensin system in normotensive and spontaneously hypertensive rats: Role of endothelium and flow, Circ Res 1995:77:303-309.
66. Benetos A, Elferlak L, Safar M, Levy B: Effects of bradykinin on carotid artery compliance: The role of the endothelium, J Hypertens 1991: 9(suppl 6):204-205.
67. Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Levy BI, Safar ME, Benetos A: Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats, Hypertension 1994:23:74-82.
68. Bcnctos A, Levy BI, Albaladejo P, Safar ME: Role of angiotensin II and bradykinin in the arterial effects of angiotensin converting enzyme inhibition in SHRs (abstract), Am J Hypertens 1995:8/2:184A
69. Chau NP, Simon A, Vilar J, Cabrera-Fischer E, Pithois-Merli I, Levenson J: Activcand passive effects of antihypertensive drugs on large artery diameter and elasticity in human essential hypertension, J Cardiovasc Pharmacol 1992:19: 78-85.
70. Barra JG, Armentano RL, Levenson J, Ca-Brera-Fischcr EI, Pichel RH, Simon A: Assessment of smooth muscle contribution to descending thoracic aortic elastic mechanics in conscious dogs, Circ Res 1993:73:1040-1050.
71. Heintz B, Walkenhorst F, Gillesscn T, Dorr R, Krebs W, Vont Dahl J, Hanrath P: In vivo characterization of segmental elastic properties of the aortic tree by intravascular ultrasound, Cardiol Elderly 1994;2:127-131.
72. Laurent S, Caviezel B, Beck L, Girerd X, Bil-laud E, Boutouyrie P, I locks A, Safar M: Carotid artery distensibility and distending pressure in hypertensive humans, Hvpertension 1994: 23:878-883.
73. Kool MJF, Van Merode T, Reneman RS, Hoeks APG, Struijkcr Boudier HAJ, Van Bor-tel LMAB: Evaluation of reproducibility of a vessel wall movement detector system for assessment of large artery properties, Cardiovasc Res 1994:28:610-614.
74. Richer C, Thuillez C, Giudicclli JG: Perindopril converting enzyme blockade and peripheral arterial hemodynamics in the healthy volunteer, J Cardiovasc Pharmacol 1987;9:94-102.
75. Pcrrct F, Mooser V, Havoz D, Tardy Y, Meister JJ, Etienne JD, Farine PA, Marazzi A, Bur-nicr M, Nussberger J, Waeber B, Brunner HR: Evaluation of arterial compliance-prcssurc curves: effect of antihypertensive drugs, Hypertension 1991; 18(suppl 2):1177-1183.
76. Bouthier JD, Safar ME, Benetos A, Simon AC, Levenson JA, Hugue CHM: Hemodynamic effects of vasodilating drugs on the common carotid and brachial circulations of patients with essential hypertension, Br J Clin Pharmacol 1986:21: 136-142.
77. Asmar RG, Pannier B, Santoni JP, Laurent S, London GM, Levy BI, Safar ME: Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension, Circulation 1988:78: 941-950.
78. Asmar RG, Journo HK, Locolley PJ, Santoni JP, Billaud E, Safar ME: One year treatment with pcrindopril: Effect on cardiac mass and arterial compliance in essential hypertension, J Hypertens 1988;6(suppl 3):33-39.
79. Dc Luca N, Savonitto S, Ricciardelli B, Mar-chegiano R, Lamenza F, Lembo G, Trintarco B: Effects of the single and repeated administration of benazepril on systemic and forearm circulation and cardiac function in hypertensive patients, Cardiovasc Drugs Thcr 1993:7: 211-216.
80. Giannattasio C, Pailla M, Stella ML, Mangoni AA, Turrini D, Carugo S, Pozzi M, Grassi G, Mancia G: Angiotensin-converting enzyme inhibition and radial artery compliance in patients with congestive heart failure, Hypertension 1995:26:491-496.
81. Bellissant E, Thuillez C, Richer C, Pussard E, Giudicelli JF: Non-invasive assessment of regional arteriolar and arterial dilating properties of lisinopril in healthy volunteers, J Cardiovasc Pharmacol 1994;24:500-506.
82. Dc Luca N, Rosiello G, Lamenza F, Ricciardelli B, Marchcgiano R, Volpe M, Marclli C, Tri-marco B: Reversal of cardiac and large artery structural abnormalities induced by long-term anthypertensive treatment with trandolapril, Am J Cardiol 1992:70:52D-59D
83. Webb DJ, Collier JG, Scidclin PH, Slruthers AD: Regulation of regional vascular tone, The role of angiotensin conversion in human forearm resistance vessels, J Hypertens 1988: 66(suppl 3):55-59.
84. Qiu HY, Henrion D, Livy BI: Endogenous angiotensin II enhances phenylephrine-induced tone in hypertensive rats, Hypertension 1994:24:317-321.
85. Stefas L, Levy BI: Effects of saralasin on arterial compliance in normotensive and hypertensive rats; role of endothelium, Hypertension 1991; 18(suppl 2):1130-1136.
86. Mombouli JV, Vanhoulte PM: Heterogeneity of endothelium-dependent vasodilator effects of angiotensin-converting enzyme inhibitors: Role of bradykinin generation during ACE inhibition, J Cardiovasc Pharmacol 1992(suppl 9):79-83.
87. Mombouli JV, Illiano S, Nagao T: Potentiation of endothelium-dependent relaxation to bradykinin by angiotensin 1 converting enzyme inhibitors in canine coronary artery involves both endothelium derived relaxing and hyper-polarizing factors, Circ Res 1992:71:137-144.
88. Hintze TH, Vainer SF: Reactive dilation of large coronary arteries in conscious dogs, Circ Res 1984:54:50-57.
89. Jat Te MD: High flow dilatation, Lancet 1981:1: 1237-1238.
90. Hilton SM: A peripheral arterial conducting mechanism underlying dilation of the femoral artery and concerned in functional vasodilatation in skeletal muscle, J Physiol 1959; 149:93- 111.
91. Pohl U, Holtz J, Busse R, Bassengc E: Crucial role of endothelium in the vasodilator response to the increased flow in vivo, Hypertension 1986:8:37-44.
92. Barenbrock M, Spieker C, Hoeks APG, Zidek W, Rahn KH: Effect of lisinopril and metopro-lol on arterial distensibility, Hypertension 1994;24(suppl 1): 161-163.
93. Shimamoto H, Shimamoto Y: Lisinopril improves aortic compliance and renal flow, Comparison with nifedipine, Hypertension 1995: 25:327-334.
94. Chen CH, Ting CT, Lin SJ, Hsu TL, Yin FCP, Siu CO, Chou P, Wang SP, Chang MS: Different effects of fosinopril and atenolol on wave reflections in hypertensive patients, Hypertension 1995;25:1034-1041.
95. Savolaincn A, Keto P, Poutancn VP, Hekali P, Standcrtskjold-N'ordenstam CG, Rames A, Kupari M: Effects of angiotensin-converting enzyme inhibition versus beta-adrenergic blockade on aortic stiffness in essential hypertension, J Cardiovasc Pharmacol 1996:27:99- 104.
96. Schartl M, Bocksch WG, Drcyssc S, Beckmann S, Franke O, Uunten U: Remodeling of myocardium and arteries by chronic angiotensin converting enzyme inhibition in hypertensive patients, J Hypertens 1994; 12(suppl 4):S37-S42.
97. De Ccsaris R, Ranieri G, Filitti V, Andirani A, Bonfantino MV: Forearm arterial distensibility in patients with hypertension: Comparative effects of long-term ACE inhibition and beta-blocking agents, Pharmacodynamics and drug action, Clin Pharmacol Ther 1993:53:360-367.
98. Girerd X, Moulin C, Boutouyrie P, Safar M, Laurent S: Normalization of the elastic modulus of large artery wall by long-term treatment in elderly essential hypertensives (abstract), Hypertension 1995.26:560.
99. Van Bortcl LM, Kool MJ, Struijkcr Boudier MA: EITecls of antihypertensive agents on local arterial distensibility and compliance, Hypertension 1995;26:531-534.
100. Ting CT, Yang TM, Chen JW, Chang MS, Yin FCP: Arterial hemodynamics in human hypertension, Effects of angiotensin converting enzyme inhibition, Hypertension 1993: 22:839-846.
101. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL: Cardiac hypertrophy, aortic compliance, peripheral resistance and wave reflection in end-stage renal disease, Comparative effects of ACE inhibition and calcium channel blockade, Circulation 1994:90:2786-2796.
102. Tsoucaris D, Benetos A, Lcgrand M, London G, Safar M: Proximal and distal pulse pressure after acute anthypertensive vasodilating drugs in Wistar-Kyoto and spontaneously hypertensive rats, J Hypertens 1995; 13:243- 249.
103. Pannier B, Garabedian VG, Madonna O, Fouchard M, Dame B, Safar ME: Lisinopril versus atenolol: Decrease in systolic versus diastolic blood pressure with converting enzyme inhibition, Cardiovasc Dings Thcr 1991;5:775-782.
104. Madhavan S, Ooi WL, Cohen H, Alderman M: Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction, Hypertension 1994;23:395-401.
105. Safar ME, Toto Moukouo JJ, Asmar RA, Laurent S: Increased pulse pressure in patients with arteriosclerosis obliterans of the lower limb, Arteriosclerosis 1987:7:232-237.
106. Asmar RG, Julia PL, Mascarel VL, Fabiani JM, Benetos A, Safar ME: Ambulatory blood pressure profile after carotid cndartereclomy in patients with ischemic arterial disease, J Hypertens 1994;12:697-702.
107. Pannier B, Brunei P, El Aroussy W, Lacolley P, Safar ME: Pulse pressure and echocardio-graphic findings in essential hypertension, J Hypertens 1989;7:127-132.
108. Bauntbach GL, Sients JE, Heistad DD: Effects of local reduction in pressure on distensibility and composition of cerebral arterioles, CircRes 1991;68:338-351.
109. Christensen KL: Reducing pulse pressure in hypertension may normalize small artery structure, Hypertension 1991:18:722-727.
110. Bauntbach GL: Effects of increased pulse pressure on cerebral arterioles, Hypertension 1996:27:159-167.
111. Kung CF, Luscher TF: Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta, Hypertension 1995: 25:194-200.
112. Creager MA, Roddy MA: Effect of captopril and enalapril on endothelial function in hypertensive patients, Hypertension 1994:24: 499-505.
113. Clozcl M: Mechanism of action of angiotensin converting enzyme inhibitors on endothelial function in hypertension, Hypertension 1991; 18(suppl 2):1137-1142.
114. Mombouli JV, Nephlali M, Vanhoutte PM: Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses, Hypertension 1991:1 (suppl 2): 1122-1129.
115. Clozcl JP, Muller RKM, Roux S, Fischli W, Baumgartner HR: Influence of the status of the rcnin-angiotensin system on the effect of cilazapril on neointima formation after vascular injury in rats, Circulation 1993:88: 1222-1227.